Business Description
NDT Pharmaceuticals Inc
NAICS : 541714
SIC : 2836
ISIN : US60649M3007
Description
NDT Pharmaceuticals Inc is a biotechnology company focused on developing revolutionary therapies for severe neurological disorders associated with traumatic brain injury. Its Nanoscale Particle Complex (NPC) technology represents the phospholipid-based nano-encapsulation delivery systems (less than 100 nanometers in diameter; mean diameter of 40 nanometers in current liquid product samples with the capability to engineer significantly smaller nanocarrier particles) that create instant delivery of payloads into the bloodstream, beginning through the membranes of the mouth. The Company is focused on developing products utilizing Intellectual Property.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 38.8 | |||||
| 9-Day RSI | 43.16 | |||||
| 14-Day RSI | 42.55 | |||||
| 6-1 Month Momentum % | -67.83 | |||||
| 12-1 Month Momentum % | -74.7 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
| Name | Current | Vs Industry | Vs History |
|---|
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:NDTP
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
NDT Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -30.426 | ||
| Beta | -600.08 | ||
| Volatility % | 746.4 | ||
| 14-Day RSI | 42.55 | ||
| 14-Day ATR ($) | 0.001498 | ||
| 20-Day SMA ($) | 0.079635 | ||
| 12-1 Month Momentum % | -74.7 | ||
| 52-Week Range ($) | 0.0225 - 0.6748 | ||
| Shares Outstanding (Mil) | 160 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
NDT Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
NDT Pharmaceuticals Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
NDT Pharmaceuticals Inc Frequently Asked Questions
What is NDT Pharmaceuticals Inc(NDTP)'s stock price today?
The current price of NDTP is $0.08. The 52 week high of NDTP is $0.67 and 52 week low is $0.02.
When is next earnings date of NDT Pharmaceuticals Inc(NDTP)?
The next earnings date of NDT Pharmaceuticals Inc(NDTP) is .
Does NDT Pharmaceuticals Inc(NDTP) pay dividends? If so, how much?
NDT Pharmaceuticals Inc(NDTP) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers